The IPO price implied a valuation of roughly 579.18 billion yuan ($85.2 billion) . By comparison, Reuters reported in October 2025 that CXMT had initially targeted a $42 billion valuation, meaning the final pricing nearly doubled that estimate
. Analysts forecast that the post-listing market cap could top 3 trillion yuan ($443 billion) and possibly reach 5 trillion yuan after trading begins
.
The IPO price valued the company at over 300 times its 2025 earnings and roughly 5 times its book value, according to a CXMT statement .
Retail investor subscriptions exceeded available shares by more than 200 times . But institutional demand was even more extreme: 285 institutions placed orders for 1.2382 trillion shares, representing approximately 462.9 times the institutional allocation. The institutional order book included 10,907 investment accounts
.
The overwhelming demand reflects both the strategic importance of China's memory-chip champion and the pent-up speculation around a rare large-scale tech IPO in a market that has seen relatively few blockbuster listings since 2022 .
Direct access to the CXMT IPO was largely blocked for global investors due to China's capital controls and regulatory restrictions on foreign participation in A-share IPOs .
A crypto trading platform called Trade.xyz stepped into the gap, launching a perpetual futures contract for CXMT on the Hyperliquid blockchain on July 15, 2026—12 days before the July 27 listing date . The contract gave traders synthetic price exposure to CXMT shares without requiring ownership of the actual STAR Market-listed stock
.
Almost immediately, the contract traded near $7.20 to $8.64 per share—roughly 52 yuan versus the 8.66 yuan IPO price, implying a 526% premium and a crypto-derived valuation around $500–535 billion, or about six times the official IPO valuation . For comparison, the IPO price of 8.66 yuan was about $1.28 at prevailing exchange rates
.
Key numbers from the Hyperliquid market:
Global investors also explored proxy trades in CXMT's supply-chain partners and peers as indirect exposure .
CXMT is China's dominant DRAM manufacturer and considered the country's best hope to challenge Samsung, SK Hynix, and Micron in memory chips—a sector critical to AI, data centers, and consumer electronics . The IPO proceeds are earmarked for expanding DRAM production capacity, including high-bandwidth memory (HBM) used in AI accelerators, a technology China has been racing to develop under U.S. export controls
.
The company's financial trajectory underscores the urgency: First-quarter 2026 revenue surged over 700% year-on-year to 50.8 billion yuan, with net profit reaching about 25 billion yuan versus a loss a year earlier . CXMT guided for first-half 2026 revenue of 110–120 billion yuan and net profit of 57 billion yuan
.
CXMT held approximately 7.7% of the global DRAM market in 2025 . Its procurement prices for some LPDDR chips are now within single-digit percentage differences of equivalent SK Hynix products, signaling narrowing technology gap
.
The massive oversubscription and valuation expectations reflect strong state-directed and market-driven support for China's "chip independence" strategy. However, analysts caution that the valuation embeds substantial downside risk if DRAM contract pricing normalizes, if AI capital expenditure slows, or if CXMT's technology gap forces price concessions when supply loosens . The IPO price at over 300 times 2025 earnings leaves little room for error
.
The disconnect between the official IPO valuation and the crypto pre-market also highlights the speculative nature of demand. Polymarket prediction markets placed a 90% probability on CXMT's market cap closing above 400 billion yuan on IPO day—still far below the $500 billion implied by the Hyperliquid contract .
CXMT is scheduled to debut on the Shanghai Stock Exchange on July 27, 2026 . It is expected to be Asia's largest IPO of 2026 and China's biggest A-share semiconductor offering since SMIC's market debut in 2020
.